[ad_1]
he Ministry of Health today authorized “emergency” use in the country of the vaccine Sputnik V, developed by the National Center for Epidemiology and Microbiology Gamaleya of Russia “against coronavirus. The first 300,000 doses that the national government was looking for will arrive in the country tomorrow and will be the first start of the vaccination campaign.
With a resolution of just three articles, the country’s health authorities authorized the use of Sputnik V based on the recommendations of the National Administration of Drugs, Food and Medical Technology (Anmat).
“ The Gam-COVID-Vac vaccine, called Sputnik V, developed by the National Center for Epidemiology and Microbiology Gamaleya of Russia, in accordance with the provisions of Articles 8 and 9 of Law 27,573 and in accordance with the recommendations of the National Administration of Drugs, Foods and Medical Technology ”, expressed the Ministry of Health in the resolution.
In the recitals of resolution 2784 which bears the signature of the Minister Gins Gonzlez Garca, it is recalled that the health portfolio signed the supply contract to acquire the vaccine registered with the International Bureau of the World Intellectual Property Organization on September 16, 2020 and that it already has the authorization to marketed in Russia.
It is also indicated that in the working group specially dedicated to the vaccine for covid-19 from the National Vaccination Commission (CO.NA.IN.) “the advances related to the development of the Sputnik V vaccine have been presented and it has given its approval.”
The National Directorate for the Fight against Noncommunicable Diseases has also prepared a technical report referring to the efficacy of the Sputnik V vaccine, “a product composed of two (2) doses: one of the adenovirus vector Ad26 (first injection) and another of Ad5 (second injection). injection), concluding that it is advisable to continue with the request for emergency authorization of the same “.
This report was approved by the Under-Secretary for Health Strategies and the Secretary for Access to Health.
In addition, it is recalled that the Sputnik V “Phase III certificate of account” provided by the Gamaleya National Center for Epidemiology and Microbiology of Russia.
.
[ad_2]
Source link